Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 30, 2014
Pharmacy Choice - Pharmaceutical News - InfoBionic Announces CE Mark Of The MoMe(TM) System For Remote Patient Monitoring For Cardiac Arrhythmias - July 30, 2014

Pharmacy News Article

 1/8/14 - InfoBionic Announces CE Mark Of The MoMe(TM) System For Remote Patient Monitoring For Cardiac Arrhythmias

LOWELL, Massachusetts, Jan. 8, 2014 /PRNewswire/ InfoBionic(TM), an emerging digital health company focused on creating superior patient monitoring solutions for chronic disease management, today announced receipt of CE Mark for the MoMe(TM) System for cardiac arrhythmia monitoring. The MoMe System is the first universal remote patient monitoring platform with seamless transition between Holter, Event, and Mobile Cardiac Telemetry (MCT) modes. The innovative platform, which leverages Cloud computing and proprietary analytics, is poised to revolutionize the $3B worldwide cardiac monitoring market by delivering on-demand access to patient data for diagnosis.

The MoMe System draws on the recent convergence of medical devices, database analytics, new sensors, and wireless protocols to provide a universal patient monitoring platform complete with real-time, high-quality patient data for improved arrhythmia detection.

"Existing cardiac patient monitoring systems have significant limitations, including poor data quality and limited data availability," stated Liviu Klein, M.D., UCSF Heart and Vascular Center. "The MoMe System provides high-quality data and real-time rhythm history as well as activity, respiration and symptom tracking that allows me to make a fast, accurate, timely and efficient medical diagnosis."

Nancy Briefs, Chief Executive Officer, commented, "We are pleased to receive CE Mark for the MoMe System. We believe the system will transform the arrhythmia monitoring market by offering superior arrhythmia detection and favorable physician practice economics. We look forward to commercializing our first product for cardiac arrhythmia monitoring in early 2014."

About InfoBionic:

InfoBionic(TM) Inc., an emerging digital health company is dedicated to transforming healthcare delivery by providing anywhere, anytime access to cardiac event monitoring with improved event detection and clinical efficacy through a lower cost business model. The MoMe(TM) System offers superior remote patient monitoring for chronic diseases with an initial market focus on cardiac arrhythmias.

For more information please visit www.infobionic.com [http://www.infobionic.com/].

InfoBionic Inc.

CONTACT: Katie Arnold, SPRIG Consulting LLC, +1-408-805-0520,
katie@sprigconsulting.com

Web site: http://www.infobionic.com/



(c) 2014 PR Newswire Europe Limited. All Rights Reserved., All Rights Reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Jul 30: Using Effective Communication to Reduce Medication Errors
Last Chance
Jul 31: Drug Diversion & the Law: Considerations for Pharmacists & Technicians
Aug 05: Treatment for Women's Health Issues in the Baby Boomer Generation
Aug 06: Pharmacy Law: HIPAA and Patient Counseling
Aug 12: Treatment and Management of Osteoporosis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415